USD $115.00
IndiaGlenvas, containing the active ingredient Lenvatinib, is a targeted therapy medication primarily used for the treatment of certain types of cancer, including thyroid cancer and hepatocellular carcinoma. It works by inhibiting specific proteins that promote cancer cell growth, thereby slowing down the progression of the disease.
Glenvas is indicated for the treatment of:
Glenvas functions as a tyrosine kinase inhibitor. It blocks the action of specific enzymes (tyrosine kinases) involved in the signaling pathways that lead to cancer cell growth and blood vessel formation, effectively starving tumors of their necessary nutrients.
Patients may experience side effects, which can include:
Consult your healthcare provider for a complete list of potential side effects and any concerns regarding your specific health situation.
Glenvas is typically taken orally in the form of a capsule. It is important to follow the prescribed dosage and schedule provided by your healthcare provider. It can be taken with or without food, but should be taken consistently either way.
Glenvas is not suitable for everyone. Individuals with a known hypersensitivity to Lenvatinib or any of the excipients should avoid this medication. Additionally, those with severe liver impairment or specific medical conditions should consult their healthcare provider before starting treatment.
Regular monitoring of blood pressure and liver function tests is recommended during treatment with Glenvas to manage potential side effects effectively. Always discuss any new symptoms or health changes with your healthcare provider.
Glenvas (Lenvatinib) offers a targeted approach to cancer treatment, providing patients with a crucial option in their therapeutic regimen. Always seek guidance from qualified healthcare professionals regarding its use and potential impacts on your health.
